# Finasteride and fertility: why the studies differ

Finasteride fertility research includes healthy volunteers and men seeking fertility care. Those populations explain why the results can look different.

Canonical: https://velri.co/blog/finasteride-fertility-question-hairline-guard-future-kids
Publisher: Velri (https://velri.co/about)
Published: 2026-07-08
Updated: 2026-09-30
Editorial policy: https://velri.co/editorial-policy

Finasteride may affect sperm counts in some men, but the research does not show the same effect in everyone. A study in healthy young men and a study in men already seeking fertility care produced different findings. Who was studied is central to interpreting them. [1][2]

## What happened in healthy volunteers?

A randomized, placebo-controlled trial studied finasteride in young men for 48 weeks. A subset provided repeated semen samples. Researchers found no significant effect on sperm concentration, total sperm count, movement or shape at the hair-loss dose studied. [1]

That is reassuring evidence for that population and time period. The study measured semen characteristics, however, rather than a person's eventual chance of becoming a parent. [1]

## What happened in a fertility clinic?

A separate study reviewed 27 men taking finasteride who presented to a male infertility clinic. Sperm counts increased in many after the medication was discontinued. Hormone measurements, sperm movement and sperm shape did not show the same change. [2]

This was a selected group with fertility concerns, not a randomized sample of all finasteride users. It suggests that susceptibility can matter; it cannot tell every person taking the medicine how likely they are to experience a fertility problem. [2]

FDA prescribing information also includes postmarketing reports of male infertility or poor semen quality, with improvement or normalization reported after discontinuation. As with other voluntary reports, these cannot reliably establish frequency or causation on their own. [3]

## What does that mean for planning a family?

The relevant details are whether pregnancy is a future goal or a current difficulty, any previous semen testing, and the medication history. Those details help frame a discussion about whether a fertility evaluation or a treatment change is appropriate. The clinic study gives particular reason to raise finasteride when low sperm counts are already part of the picture. [2]

Pregnancy exposure is a separate issue. FDA labeling says people who are pregnant or may become pregnant should not handle crushed or broken finasteride tablets because of potential risk to a male fetus. Intact tablets have a coating that prevents contact during normal handling. [3]

## Sources
[1] Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men. (1999). https://pubmed.ncbi.nlm.nih.gov/10492183/
[2] Finasteride use in the male infertility population: effects on semen and hormone parameters - PubMed (2013). https://pubmed.ncbi.nlm.nih.gov/24012200/
[3] PROPECIA (finasteride) tablets: prescribing information (2022). https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020788s030lbl.pdf

## About this information
General health information, not personal medical advice, diagnosis or treatment. A prescription is required and is never guaranteed.
Velri is a brand operated by Velri Management LLC, a Nevada limited liability company. Velri is a non-clinical technology and administrative services company. Velri does not provide medical advice, diagnosis, treatment, or pharmacy services, and does not direct the clinical judgment of any provider.
All medical consultations and prescriptions are provided directly by independent provider groups (Online Medical Care, P.C.; TMD of Kansas, P.A.; TMD of Texas, P.A.; and TMD of CA, PC), by a provider licensed in your state. Velri does not employ providers. A prescription is issued only if a provider determines it is clinically appropriate in their independent medical judgment.
All prescription products are dispensed by independent, licensed pharmacies. Velri does not own, operate, or control any pharmacy and does not dispense medication. You may opt out of using a given provider group or pharmacy at any time.
Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state.
Velri is cash-pay. We do not bill Medicare, Medicaid, or commercial insurance. Refunds and order problems are addressed in the Terms of Use; your rights under applicable law are not limited. State availability and clinical eligibility apply.
Velri and telehealth are not for medical emergencies. If you are experiencing an emergency, call 911.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Care is available to eligible adults 18 and older in 47 states and D.C., United States only.
Notice of Privacy Practices: https://velri.co/privacy/notice-of-privacy-practices
Terms: https://velri.co/legal/terms
Provider group or pharmacy opt-out help: https://velri.co/contact and https://velri.co/standards#trust-support